About us

Viral vector specialists 
at the heart of a rapidly growing industry

OXB is one of the original pioneers in gene and cell therapy. We’re already collaborating with some of the world’s most innovative pharmaceutical and biotechnology companies towards a shared mission: to make cell and gene therapy a universally accessible clinical option.

0+

Over 25 years of experience

0+

Successful GMP batches

~0

Global active clients

0+

Countries with approved products using our vectors

Our people & client relationships

Our talented, dedicated people devise flexible solutions to meet clients’ specific needs. We support clients every step of the way, collaborating to take therapies to the clinic and beyond.

Meet the team

Our platforms

We ensure cost-effective and on-time delivery to clients by applying technical expertise, helping solve industry wide challenges around safety, efficacy, and yields. We help our clients improve their product yield and reduce product wastage.

LentiVector® platform
inAAVate™ platform

State-of-the-art facilities in the UK, US, and France

We can accommodate a variety of vector types, processes and batch volumes across our suites in the UK, US, and France. Our state-of-the-art, automated fill-finish facilities package vectors ready for clinical or commercial use.

Stay in touch

Subscribe to receive OXB's latest news, events and insights

Stay in touch - Subscribe

Privacy policy(Required)